Arnold Susan Elizabeth
Insider CIK 1755746 · PHAS VP, Preclinical and Chem.
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PHAS PhaseBio Pharmaceuticals I | A Award | 2022-05-20 | 2022-05-24 | 10,917 | $0.68 | $7.4K | 41,236 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2022-02-24 | 2022-02-28 | 18,750 | — | $0 | 18,750 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2022-02-24 | 2022-02-28 | 87,500 | — | $0 | 87,500 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award | 2021-11-19 | 2021-11-23 | 2,559 | $2.01 | $5.1K | 30,319 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2021-07-12 | 2021-09-03 | 4,519 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award | 2021-07-12 | 2021-07-14 | 4,519 | $1.74 | $7.9K | 27,760 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise | 2021-07-12 | 2021-09-03 | 4,519 | $1.74 | $7.9K | 27,760 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award | 2021-05-20 | 2021-05-24 | 5,257 | $2.80 | $14.7K | 23,241 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2021-02-05 | 2021-02-09 | 36,000 | — | $0 | 36,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award | 2020-11-20 | 2020-11-23 | 4,832 | $3.00 | $14.5K | 17,984 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2020-10-01 | 2020-10-05 | 5,423 | $1.15 | $6.2K | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise | 2020-10-01 | 2020-10-05 | 5,423 | $1.15 | $6.2K | 13,152 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2020-02-27 | 2020-10-05 | 5,423 | $1.15 | $6.2K | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise | 2020-02-27 | 2020-10-05 | 5,423 | $1.15 | $6.2K | 7,729 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2020-02-12 | 2020-02-14 | 55,000 | — | $0 | 55,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2019-02-27 | 2019-03-01 | 45,000 | — | $0 | 45,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 103 | $0.12 | $12 | 2,306 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 2,306 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 103 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 2,306 | — | $0 | 2,306 | SEC↗ |